Back to Results
First PageMeta Content
Muscular dystrophy / Pharmaceutical sciences / Health / Science / Food and Drug Administration / Clinical trial / Dystrophin / Drug development / Duchenne muscular dystrophy / Pharmacology / Drug discovery / Pharmaceutical industry


Accelerating Access to Treatments of Duchenne CureDuchenne and Prosensa Debra Miller, Founder and CEO, CureDuchenne Celia Economides, Sr Director, IR and Corporate Communications, Prosensa
Add to Reading List

Document Date: 2014-12-01 15:31:54

Open Document

File Size: 427,33 KB

Share Result on Facebook

Company

CureDuchenne Ventures LLC / /

Continent

North America / Europe / /

Country

United States / /

Currency

EUR / /

Organization

European Union / /

Person

Celia Economides / Debra Miller / Celia Economides / Sr / /

Position

Director / IR and Corporate Communications / CEO / Sr Director / /

Technology

drug development / /

SocialTag